The largest database of trusted experimental protocols

Total egfr antibody

Manufactured by Cell Signaling Technology
Sourced in United States

The Total EGFR antibody is a primary antibody that recognizes the full-length epidermal growth factor receptor (EGFR) protein. It can be used to detect and quantify EGFR expression levels in various cell and tissue samples.

Automatically generated - may contain errors

3 protocols using total egfr antibody

1

Investigating EGFR and Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human recombinant EGF and human recombinant TNF were purchased from Peprotech (Rocky Hill, NJ, USA). Gefitinib was kindly provided by AstraZeneca (Tokyo, Japan). TAPI-1 was from Calbiochem (San Diego, CA, USA). The following antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA): Total EGFR antibody (#4267), phospho-EGFR (Y1068) antibody (#3777), total AKT antibody (#9272), phospho-AKT (S473) antibody (#9271), total ERK1/2 antibody (#9102), phospho-ERK1/2 antibody (#4370), phospho-MKK3/6 antibody (#9236), total p38 MAPK antibody (#9212), phospho-p38 MAPK antibody (#9211), TACE antibody (#3976), and β-actin antibody (#4970). Meanwhile, antibodies specific to total MKK 3/6 (sc-13069) was purchased from Santa Cruz Biotechnology, Dallas, TX, USA. Cetuximab was purchased from Showa University Hospital (Shinagawa, Tokyo, Japan). Materials used for western blot analysis were from Bio-Rad Laboratories (Richmond, CA, USA). Dulbecco’s modified Eagle medium (DMEM) and all other materials were purchased from Sigma Chemical (St. Louis, MO, USA) unless otherwise stated. All pharmacological inhibitors and agonists were dissolved in DMSO and added to the medium with a final DMSO concentration of <0.1%.
+ Open protocol
+ Expand
2

Isolation and Lysis of Colonoid Cells for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare total protein lysates, colonoids were harvested using BD Cell Recovery Solution in order to achieve Matrigel matrix depolymerization. The wells were washed with cold PBS and incubated for 60 minutes in cold BD Cell Recovery Solution. Once the colonoids were released, the cells were centrifuged at 800rpm for 5 minutes at 4°C. The pellet was homogenized in lysis buffer containing a mixture of proteinase and phosphatase inhibitors and then centrifuged at 15,000rpm for 15 min at 4°C. The protein concentration was determined using a BCA Protein Assay Kit (Pierce, Rockford, IL). Total protein was resolved on 4–12% precasted SDS-PAGE gels, then transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA). The PVDF membrane was blocked with 5% non-fat milk in PBS containing 0.1% Tween 20 for 2 h at room temperature and then incubated overnight at 4°C with primary antibodies. The following antibodies were used in this study: GAPDH, anti-EGFR (phosphor Y1068) (1:2000, abcam, USA), total-EGFR, P-ERK, total-EGFR antibody (1:1000, cell signaling, USA). After washing with TBST, the blots were incubated for 2h at room temperature with HRP-conjugated secondary antibody (1:5000; Amersham Biosciences, San Francisco, CA, USA), visualized by using Electro-Chemi-Luminescence (ECL) chemiluminescent detection system (Amersham Biosciences).
+ Open protocol
+ Expand
3

Phospho-specific antibodies and inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phospho-specific antibodies against ERK (Thr-202 and Tyr-204), Akt (Ser-473), p90RSK (Ser-380), EGFR (Thr-669), ErbB2 (Tyr-1196 and Tyr-1248) and ErbB3 (Tyr-1289), and total EGFR antibody were purchased from Cell Signaling Technology (Danvers, MA, USA). Antibodies against EGFR, ErbB2, ErbB3, Akt1 and Actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Recombinant human epidermal growth factor (EGF), heregulin (HRG), and fibroblast growth factor-2 (FGF-2) were purchased from R&D Systems (Minneapolis, MN, USA). SB203580, SP600125, U0126, and LY294002 were obtained from Merck Biosciences (Darmstadt, Germany). Lapatinib and trametinib were obtained from AdooQ BioScience (Irvine, CA, USA) and Cayman Chemical (Ann Arbor, MI, USA), respectively. SCH772984 was purchased from Chemietek (Indianapolis, IN, USA). TPA and Phos-tag ligand were purchased from WAKO Pure Chemical Industries (Osaka, Japan). All chemical agents were dissolved in DMSO, and the final concentration of DMSO was less than 0.1%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!